Intimation that representative(s) of TA Associates, would be having a meeting with us at 2.30 P.M. on Thursday, April 11, 2019 at the Corporate Office of the Company, followed by a visit to our Lab.
Intimation about the following analyst meetings to be held at our corporate office:
i) Meeting with the representative(s) of Arisaig Partners, at 03.00 P.M. on Friday, April 05, 2019, to be followed by a visit by them to our Lab.
ii) Meeting with the representative(s) of Edelweiss Securities Limited, at 3.30 P.M. on Friday, April 05, 2019, to be preceded by a visit by them to our Lab.
Intimation about the following Analyst Meetings:
i) Meeting with the representative(s) of Sands Capital Management, at 12.30 P.M. on Monday, March 25, 2019 at the Corporate Office of the Company, followed by Lab Visit.
ii) Participation of our representative at 1st Annual Edition of “INDIA IDEATION CONFERENCE” Organized by Motilal Oswal at Hotel Grand Hyatt, Mumbai on Wednesday, March 27, 2019 from 9.00 A.M. to 6.00 P.M, where he will meet representatives of various fund houses.
iii) Meeting with the representative(s) of Goldman Sachs India Securities Ltd., at 3.30 P.M. on Friday, March 29, 2019 at the Corporate Office of the Company.
Intimation about the following Analyst Meetings :
i) Meeting of the representative(s) of Way2Wealth, a Coffee Day Company, at 11.30 A.M. on Wednesday, March 20, 2019 at the Corporate Office of the Company.
ii) Meeting of the representative(s) of SAIF Partners, at 06.00 P.M. on Monday, March 25, 2019 at Hotel Grand Hyatt, Mumbai.
Intimation about the following Analyst Meetings / Con-call, to be held at our corporate office:
i) Con-call between us and the representatives of Motilal Oswal Mutual Fund, at 3.00 P.M. on Monday, March 11, 2019.
ii) Meeting of the representative(s) of Capital International, at 09.30 A.M. on Tuesday, March 12, 2019.
iii) Meeting of the representative(s) of Seven Canyons Advisors, at 10.00 A.M. on Wednesday, March 13, 2019.
Intimation about the following analyst meetings to be held at our corporate office:
i) Meeting of the representative(s) of TA Associates, at 10.00 A.M. on Tuesday, February 26, 2019.
ii) Meeting of the representative(s) of Haitong Securities India Private Limited, at 3.30 P.M. on Wednesday, February 27, 2019.
Intimation about the following analyst meetings to be held at our corporate office:
i) Meeting of the representative(s) of Lohia Securities Limited, at 11.00 A.M. on Monday, February 25, 2019.
ii) Meeting of the representative(s) of TR Capital, at 11.00 A.M. on Tuesday, February 26, 2019.
Post-script of the conference call of Indian and Overseas Investors held on 12-02-2019 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /nine months ended 31-12-2018 Click here
Intimation about the following analyst meetings to be held at our corporate office:
i) Meeting of the representative(s) of Consortium Securities Private Limited, at 3.30 P.M. on Friday, February 22, 2019.
ii) Meeting of the representative(s) of Pragya Equities Private Limited, at 5.00 P.M. on Wednesday, February 27, 2019.
Intimation about the following analyst meetings to be held at our corporate office:
i) Meeting of the representative(s) of Ambit Capital Private Limited, at 4.00 P.M. on Wednesday, February 20, 2019.
ii) Meeting of the representative(s) of InvesQ Equity Investment Advisor, at 11.00 A.M. on Thursday, February 21, 2019.
iii) Meeting of the representative(s) of India Ratings & Research Private Limited, a Fitch Group Company, at 4.00 P.M. on Thursday, February 21, 2019.
Intimation about conference call for Indian and Overseas Investors to be held on 12-02-2019 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2018.
Intimation that Dr. A. Velumani, Chairman, Managing Director & CEO, would be participating at ‘10th Eureka Conference- London’ organized by M/s. Motilal Oswal Financial Services Limited, at St James Court, A Taj Hotel, London on 11th and 12th February 2019, where representatives of various fund houses would be meeting him.
Intimation that Dr. A. Velumani, Chairman & Managing Director, would be participating at ‘10th Enterprising India Investors’ Conference organized by M/s. IIFL- Institutional Equities, at Hotel Trident BKC, Mumbai, on Wednesday, 13th February 2019, where representatives of various fund houses would be meeting him, from 02.00 P.M to 6.00 P.M.
Intimation that Mr. Sachin Salvi, General Manager- Finance would be participating at ‘Build India, New India’ Investor Conference organized by M/s. Antique Stock Broking Limited, at Hotel Sofitel BKC, Mumbai, on Tuesday, 12th February 2019, where representatives of various fund houses would be meeting him, from 10.00 A.M to 2.00 P.M.
Intimation about Board Meeting scheduled to be held on February 09, 2019 to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended 31st December 2018 and to consider declaration of interim dividend, if any.
Intimation about closure of Trading Window for Directors, Employees and Connected Persons from January 29, 2019 to February 12, 2019. (both days inclusive).
Intimation that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chairman, Managing Director & CEO, Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, Dr. Caesar Sengupta, Vice-President-Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Monday, December 17, 2018.
Intimation that Mr. Robert Harvey and Mr. Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde,Deputy General Manager- Finance at Hotel Trident, BKC by 09.00 A.M. on Wednesday, December 05, 2018.
Intimation that Mr. Kalpesh Parekh, Vice President- Institutional Sales and Mr. Surajit Pal, Analyst of Prabhudas Lilladher Pvt. Ltd. would be having a meeting with Dr. Caesar Sengupta, Vice-President- Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 03.30 P.M. on Wednesday, December 05, 2018.
Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at B & K’s Investor Conference- Emergent India- 2018 organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident BKC, Mumbai, on Wednesday, 5th December 2018, where the representatives of various Funds would be meeting, from 10.00 A.M to 6.00 P.M.
Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at Annual C.H.A.M.P.S. Conference organized by M/s. Spark Capital Advisors (India) Private Limited, at Hotel Trident BKC, Mumbai, on Friday, 16th November 2018, where they would be meeting representatives of various Funds, between 10.00 A.M. and 2.00
Post-script of the conference call of Indian and Overseas Investors held on 12-11-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /half year ended 30-09-2018.View Here
Intimation that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference ‘The Stock called India’ organized by M/s. IDFC Securities Limited, at Hotel Grand Hyatt, Mumbai, on Wednesday, 21st November 2018, where he would be meeting various investors between 2.00 P.M and 6.00 P.M.
Address: D37/1, MIDC-Turbhe, Navi Mumbai
Email: investor_relations@thyrocare.com
Tel: +9122 4125 2525 / 3090 0000
CIN – L85110MH2000PLC123882
ISIN – INE594H01019